The Benefits of TAVR for Cardiac Patients at All Risk Levels
NYU Langone’s Dr. Mathew Williams and the Heart Valve Center team play a key role as FDA approves TAVR for cardiac patients at all risk levels.
Whole-Eye & Partial-Face Transplant Is a World First
A surgical team at NYU Langone Health performed the world’s first whole-eye and partial-face transplant for a 46-year-old military veteran.
Cancer Treatment & Research Enhanced on Long Island
Perlmutter Cancer Center at NYU Langone Hospital—Long Island has become a hub for cancer treatment and research on Long Island.
Request for Documents
... Date: (mm/dd/yyyy) Registration & Student Records 550 1st Avenue, Medical Science Building, Suite G90 ...
Combination of Vaccine & Immunotherapy Counters Melanoma
NYU Langone researcher Dr. Jeffrey S. Weber led a clinical trial that found adding a vaccine to an immunotherapy reduced melanoma recurrence.
Experimental Compound Shows Promise for Rare Disease
Researchers at NYU Langone discovered a biological pathway that controls cellular energy and designed a drug that countered a related neurologic disease.
Extraordinary Teamwork in OR Saves Patient with Lung Cancer
Dr. Harvey Pass, chief of thoracic surgery at NYU Langone, leads a heroic effort to save a patient who goes into cardiac arrest in the OR.
Navigating a Prostate Cancer Diagnosis
Urologic oncologists from NYU Langone’s Perlmutter Cancer Center explain prostate cancer diagnosis and treatments such as radical prostatectomy.
NYU Langone Health in the News—July 17, 2024
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from July 17, 2024.
NYU Langone Health in the News—Tuesday 24, 2025
At NYU Langone, our experts are frequently featured in various media outlets to share their skills and knowledge. See the stories from June 24, 2025.